IRIS BIOTECHNOLOGIES INC: 10-Q filed 2013-08-14

Name: IRIS BIOTECHNOLOGIES INC: 10-Q filed 2013-08-14
Creator: IRIS BIOTECHNOLOGIES INC
License: https://creativecommons.org/licenses/by/4.0/

What IRIS BIOTECHNOLOGIES INC reported in its quarterly report filed 2013-08-14 (fiscal Q2 2013): 24 published measures, 70 facts as tagged in accession 0001554795-13-000478.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-08-14
Fiscal period: fiscal Q2 2013
Accession: 0001554795-13-000478 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All IRIS BIOTECHNOLOGIES INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2013-06-30	7,677	USD
At 2012-12-31	24,720	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2013-06-30	215,519	USD
At 2012-12-31	143,803	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2013-06-30	-207,842	USD
At 2012-12-31	-119,083	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2013-06-30	1,095	USD
At 2012-12-31	1,042	USD
At 2012-06-30	53,083	USD
At 2011-12-31	43,729	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	-109,975	USD	91
2013-01-01 to 2013-06-30	-213,095	USD	181
1999-02-16 to 2013-06-30	-9,404,766	USD	5249
2012-04-01 to 2012-06-30	-99,470	USD	91
2012-01-01 to 2012-06-30	-270,925	USD	182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	-53,147	USD	181
1999-02-16 to 2013-06-30	-3,399,533	USD	5249
2012-01-01 to 2012-06-30	-65,646	USD	182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
1999-02-16 to 2013-06-30	228,371	USD	5249

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	53,200	USD	181
1999-02-16 to 2013-06-30	3,628,999	USD	5249
2012-01-01 to 2012-06-30	75,000	USD	182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
1999-02-16 to 2013-06-30	-228,371	USD	5249

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	13,167,447	shares	91
2013-01-01 to 2013-06-30	13,133,907	shares	181
2012-04-01 to 2012-06-30	12,719,183	shares	91
2012-01-01 to 2012-06-30	12,686,598	shares	182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	-0.01	USD/shares	91
2013-01-01 to 2013-06-30	-0.02	USD/shares	181
2012-04-01 to 2012-06-30	-0.01	USD/shares	91
2012-01-01 to 2012-06-30	-0.02	USD/shares	182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2013-06-30	6,048	USD
At 2012-12-31	8,964	USD

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2013-06-30	1,629	USD
At 2012-12-31	15,756	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2013-06-30	155,519	USD
At 2012-12-31	96,803	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2013-06-30	155,319	USD
At 2012-12-31	96,803	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	108,890	USD	91
2013-01-01 to 2013-06-30	211,048	USD	181
1999-02-16 to 2013-06-30	9,613,039	USD	5249
2012-04-01 to 2012-06-30	99,408	USD	91
2012-01-01 to 2012-06-30	270,863	USD	182

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	100,327	USD	91
2013-01-01 to 2013-06-30	196,372	USD	181
1999-02-16 to 2013-06-30	5,328,760	USD	5249
2012-04-01 to 2012-06-30	81,225	USD	91
2012-01-01 to 2012-06-30	231,541	USD	182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	7,118	USD	91
2013-01-01 to 2013-06-30	11,760	USD	181
1999-02-16 to 2013-06-30	2,213,277	USD	5249
2012-04-01 to 2012-06-30	13,908	USD	91
2012-01-01 to 2012-06-30	31,015	USD	182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2013-06-30	13,189,573	shares
At 2012-12-31	13,034,573	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2013-06-30	2,452,945	USD
At 2012-12-31	2,409,725	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2013-06-30	238,800	USD
At 2012-12-31	238,800	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2013-06-30	232,752	USD
At 2012-12-31	229,836	USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	1,445	USD	91
2013-01-01 to 2013-06-30	2,916	USD	181
1999-02-16 to 2013-06-30	232,752	USD	5249
2012-04-01 to 2012-06-30	4,275	USD	91
2012-01-01 to 2012-06-30	8,307	USD	182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	40,000	USD	181
1999-02-16 to 2013-06-30	3,317,845	USD	5249
2012-01-01 to 2012-06-30	40,000	USD	182

Inspect the source

Entity: IRIS BIOTECHNOLOGIES INC / CIK 0001396238
Captured: 2026-09-23 02:52 UTC
SEC response SHA-256: f69a5b6b6186f6dfc2d7906e354cee921fb25b7d8f16aeffb5503cb3890a50e7

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001396238.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))